Cinctive Capital Management LP Qiagen N.V. Transaction History

Cinctive Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $1.95 Million - $2.41 Million	-47,710 Reduced 72.53%	18,072 $746,000
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $262,478 - $303,945	-6,107 Reduced 8.5%	65,782 $3.11 Million
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $117,526 - $151,116	2,783 Added 4.03%	71,889 $3.52 Million
Q4 2021 Feb 14, 2022	BUY	$50.62 - $56.47 $1.98 Million - $2.21 Million	39,106 Added 130.35%	69,106 $3.84 Million
Q3 2021 Nov 15, 2021	BUY	$46.55 - $56.83 $1.4 Million - $1.7 Million	30,000 New	30,000 $1.55 Million

Q1 2020 May 15, 2020	SELL	$33.17 - $41.6 $6.3 Million - $7.9 Million	-190,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$25.41 - $43.1 $4.83 Million - $8.19 Million	190,000 New	190,000 $6.42 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.